ISOT MIDTERM GOA 2025 
Renal Transplant Pathology Webinar Schedule
|
Sr No
|
Date
|
Time
|
Topics
|
Speaker
|
|---|---|---|---|---|
|
1.
|
20/12/2023
|
6:30 pm to 7:15 pm
|
FROM NEEDLE TO SLIDE:-1. Processing of a renal transplant biops 2. Evaluation of the donor kidney 3. Evaluation of the allograft kidney
|
Dr. Radhika Krishna Patil
|
|
2.
|
03/01/2024
|
6:30 pm to 7:15 pm
|
Acute T-cell-mediated rejection i. Tubulointerstitial (Banff type I and borderline/suspicious) ii. Endarteritis (Banff type II) iii. Arterial transmural inflammation or fibrinoid necrosis (Banff type III).
|
Dr. Swarnalata Gowrishankar
|
|
3.
|
17/01/2024
|
6:30 pm to 7:15 pm
|
ChronicT-cell-mediated rejection i. Tubulointerstitial inflammation and fibrosis ii. Transplant arteriopathy *Chronic Active T -cell Mediated Rejection
|
Dr. Radhika Krishna Patil
|
|
4.
|
07/02/2024
|
6:30 pm to 7:15 pm
|
Antibody-mediated rejection 1 . Hyperacute 2. Acute i. Acute tubular injury (Banff type I) ii. Capillaritis (Banff type II) iii. Arterial fibrinoid necrosis (Banff type III)
|
Dr. Mahesha Vankalakunti
|
|
5.
|
21/02/2024
|
6:30 pm to 7:15 pm
|
Post Renal Transplant De novo glomerular diseases: Focal segmental glomerulo-sclerosis, diabetic nephropathy,Membranous Nephropathy
|
Dr. Shaila Khubchandani
|
|
6.
|
06/03/2024
|
6:30 pm to 7:15 pm
|
Antibody mediated rejection in renal Transplantation: perspectives
|
Dr. Aruna Vanikar
|
|
7.
|
20/03/2024
|
6:30 pm to 7:15 pm
|
TMA(Thrombotic Microangiopathy) in Renal Allograft
|
Dr. Pallav Gupta
|
|
8.
|
03/04/2024
|
6:30 pm to 7:15 pm
|
Protocol biopsies
|
Dr. Kamal Kannodia
|
|
9.
|
17/04/2024
|
6:30 pm to 7:15 pm
|
Post Renal Transplant Drug toxicity 1. CNI toxicity (cyclosporine, tacrolimus) 2. mTOR inhibitor toxicity (rapamycin, sirolimus) 3. Antiviral drug tubular toxicity (foscarnet, adefovir, tenofovir) 4. Acute allergic tubulointerstitial nephritis
|
Dr. Vinita Agarwal
|
|
10.
|
01/05/2024
|
6:30 pm to 7:15pm
|
Post Renal Transplant Viral Infections i. Polyomavirus ii. Adenovirus iii. Cytomegalovirus iv. Herpes simplex
|
Dr. Anila Abraham
|
|
11.
|
15/05/2024
|
6:30 pm to 7:15pm
|
Post Renal Transplant Bacterial/Fungal Infections i. Acute/chronic pyelonephritis ii. Tuberculosis iii. Malakoplakia
|
Dr. Seethalakshmy
|
|
12.
|
05/06/2024
|
6:30 pm to 7:15pm
|
Evaluation of Post renal transplant Proteinurea:Pathologist Perspective
|
Dr. Shrinivas Bh
|
|
13.
|
19/06/2024
|
6:30 pm to 7:15 pm
|
ChronicAntibody- mediated rejection i. Transplant glomerulopathy ii. Multilamination PTC basement membranes iii. Transplant arteriopathy. *Chronic active ABMR
|
Dr. Ritambara Nada
|
|
14.
|
03/07/2024
|
6:30 pm to 7:15 pm
|
Post renal transplant lymphoproliferative disease Idiopathic: interstitial fibrosis and tubular atrophy, not otherwise classified (IF/TA, NOS)].
|
Dr. Manoj Jain
|
|
15.
|
17/07/2024
|
6:30 pm to 7:15 pm
|
Post Renal Transplant Recurrent primary diseases A. Immunologic: IgA nephropathy, Lupus nephritis, anti-GBM disease B. Metabolic: amyloidosis, diabetes, oxalosis C. Other: dense deposit disease, focal segmental glomerulosclerosis
|
Dr. Geetika Singh
|
|
16.first talk
|
07/08/2024
|
6:30 pm to 6:50pm
|
Hyperperfusion injury: An Interesting case
|
Dr. Vrushali Deshpande
|
|
16.second talk
|
07/08/2024
|
6:50 pm to 7:15 pm
|
Course Summary In Nutshell
|
Dr. Radhika Krishna Patil
|
|
17.
|
21/08/2024
|
6:30 pm to 7:15 pm
|
Role of an Electron Microscopy in Renal allograft biopsies
|
Dr. Alok Sharma
|
| SR. NO. | DATE | TIME | TOPICS |
| 1. | 20/12/2023 | 6.30 pm to 7.15pm | FROM NEEDLE TO SLIDE 1. Processing of a renal transplant biopsy 2. Evaluation of the donor kidney 3. Evaluation of the allograft kidney |
| 2. | 03/01/2024 | 6.30 pm to 7.15pm | Acute T-cell-mediated rejection i. Tubulointerstitial (Banff type I and borderline/suspicious) ii. Endarteritis (Banff type II) iii. Arterial transmural inflammation or fibrinoid necrosis (Banff type III). |
| 3. | 17/01/2024 | 6.30 pm to 7.15pm | ChronicT-cell-mediated rejection i. Tubulointerstitial inflammation and fibrosis ii. Transplant arteriopathy *Chronic Active T -cell Mediated Rejection |
| 4. | 07/02/2024 | 6.30 pm to 7.15pm | Antibody-mediated rejection 1 . Hyperacute 2. Acute i. Acute tubular injury (Banff type I) ii. Capillaritis (Banff type II) iii. Arterial fibrinoid necrosis (Banff type III) |
| 5 | 21/02/2024 | 6.30 pm to 7.15pm | ChronicAntibody-mediated rejection i. Transplant glomerulopathy ii. Multilamination PTC basement membranes iii. Transplant arteriopathy. *Chronic active ABMR |
| 6 | 06/03/2024 | 6.30 pm to 7.15pm | Variants of Antibody-mediated rejection i. Smoldering/indolent (mononuclear capillaritis) ii. C4d deposition without evidence of active rejection / Accomodation iii. C4d-negative (mostly chronic or smoldering) |
| 7 | 20/03/2024 | 6.30 pm to 7.15pm | TMA(Thrombotic Microangiopathy) in Renal Allograft |
| 8 | 03/04/2024 | 6.30 pm to 7.15pm | Protocol biopsies |
| 9 | 17/04/2024 | 6.30 pm to 7.15pm | Post Renal Transplant Drug toxicity 1. CNI toxicity (cyclosporine, tacrolimus) 2. mTOR inhibitor toxicity (rapamycin, sirolimus) 3. Antiviral drug tubular toxicity (foscarnet, adefovir, tenofovir) 4. Acute allergic tubulointerstitial nephritis |
| 10. | 01/05/2024 | 6.30 pm to 7.15pm | Post Renal Transplant Viral Infections i. Polyomavirus ii. Adenovirus iii. Cytomegalovirus iv. Herpes simplex |
| 11. | 15/05/2024 | 6.30 pm to 7.15pm | Post Renal Transplant Bacterial/Fungal Infections i. Acute/chronic pyelonephritis ii. Tuberculosis iii. Malakoplakia |
| 12. | 05/06/2024 | 6.30 pm to 7.15pm | Evaluation of Post renal transplant Proteinurea:Pathologist Perspective |
| 13. | 19/06/2024 | 6.30 pm to 7.15pm | Post Renal Transplant De novo glomerular diseases: Focal segmental glomerulo-sclerosis, diabetic nephropathy,Membranous Nephropathy |
| 14. | 03/07/2024 | 6.30 pm to 7.15pm | Post renal transplant lymphoproliferative disease Idiopathic: interstitial fibrosis and tubular atrophy, not otherwise classified (IF/TA, NOS)]. |
| 15. | 17/07/2024 | 6.30 pm to 7.15pm | Post Renal Transplant Recurrent primary diseases A. Immunologic: IgA nephropathy, Lupus nephritis, anti-GBM disease B. Metabolic: amyloidosis, diabetes, oxalosis C. Other: dense deposit disease, focal segmental glomerulosclerosis |
| 16.first talk | 07/08/2024 | 6.30 pm to 6.50pm | · Hyperperfusion injury: An Interesting case |
| 16.sec. talk | 07/08/2024 | 6.50 pm to 7.15pm | Course Summary In Nutshell |
| 17. | 21/08/2024 | 6.30 pm to 7.15pm | Role of an Electron Microscopy in Renal allograft biopsies |
EXAM- 28/08/2024 & Results- 31/08/2024.
Dr. RADHIKA KRISHNA PATIL
Convenor& Program Incharge
MBBS, MD(Pathology), D.P.B, FISN-ANIO,
PDCC(Renal & Transplant Pathology)
Vice-President ISOT-Indian Society of Organ
Transplantation-Basic Sciences,
Director & Consultant Nephropathologist,
Sri Balaji Diagnostics, Madhapur Hyderabad